Entering text into the input field will update the search result below

Monte Rosa Therapeutics EPS beats by $0.03

  • Monte Rosa Therapeutics (NASDAQ:GLUE): Q3 GAAP EPS of -$0.43 beats by $0.03.
  • Cash and cash equivalents as of Sept. 30, 2021, were $367.0 million.
  • Press Release

Recommended For You

More Trending News

About GLUE Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
GLUE--
Monte Rosa Therapeutics, Inc.